. Intriguingly, treatment of T cells with the Janus kinase (JAK) inhibitor tofacitinib disproportionately altered the expression of rheumatoid arthritis risk genes with SE structures. Together, these results indicate that genes with SE architecture in T cells encompass a variety of cytokines and cytokine receptors but are controlled by a 'guardian' transcription factor, itself endowed with an SE. Thus, enumeration of SEs allows the unbiased determination of key regulatory nodes in T cells, which are preferentially modulated by pharmacological intervention.
Histone acetyltransferase p300 loading demarcates regions of the genome bearing SE architecture 2, 8 . Using chromatin immunopreciptiation followed by sequencing (ChIP-seq) for the p300 protein, we constructed SE catalogues of murine CD4 1 T helper (T H )1, T H 2 and T H 17 cells. As predicted 2 , the p300 load is exponentially distributed throughout the genome (Fig. 1a and Extended Data Fig. 1a ). Approximately 40% of the p300 signal was found in a small fraction of p300-loaded enhancers in each lineage. The distribution of SEs was lineage-specific even in these closely related cells (Fig. 1b and Extended Data Fig. 1b) . Regulatory regions of lineage-specific master transcription factors were endowed with SEs only in the relevant lineage (Extended Data Fig. 1c) . We addressed the relationship between SEs and transcriptional activity in T cells by assigning SEs to associated genes using proximity measures 4 , bearing in mind that alternative methods can conclusively establish such associations 6, 9 . We found that SE architecture conferred significantly higher transcriptional activity compared with typical enhancer (TE) architecture and that this transcriptional activity was lineage-specific ( Fig. 1c, d) .
Widespread transcription at SEs themselves has been reported in embryonic stem (ES) cells and myogenic cells 2, 10 . We next explored the extent to which SE domains were transcribed in T cells by employing high-resolution temporal expression maps of intergenic noncoding RNAs (ncRNAs) 11 . One-third of the ncRNAs expressed in T cells (501/1,524) were transcribed from an SE 10 ( Fig. 1e and Extended Data Fig. 1d ).
Controlling for differences in the size of SEs and TEs, we found 80 ncRNAs per 10 megabase pairs (Mb) of SEs compared with 51 transcripts within TEs. The presence of an SE structure also distinguished highly lineage-specific and dynamic ncRNAs from constitutively expressed ones ( Fig. 1f-h ).
To elucidate the potential role of SEs in T-cell biology, we used ChIPseq data sets to catalogue binding profiles of 13 transcription factors with major roles in T H -cell differentiation across the merged map of SEs [12] [13] [14] [15] ( Fig. 2a- 
c). As in ES cells 2 , STATs prominently bound SEs in CD4
1 T cells (Fig. 2a, d ). Similarly, BATF, IRF4 and BACH2 were enriched at these regions ( Fig. 2b, d ). Lineage-specific transcription factors such as T-BET, GATA3 and ROR-ct showed preferential binding at lineage-specific SEs (Extended Data Fig. 2a) . CTCF, an essential genome organizer, appeared to preferentially demarcate SE boundaries 6 (Extended Data Fig. 2b) . Comparison of the enrichment of transcription factors at SEs and TEs revealed selective binding of STAT3 at SEs whereas other transcription factors demonstrated comparable binding at SEs and TEs (Extended Data Fig. 2c ).
We next compared the identity of SE-associated genes in T cells with those in other cell lineages. In ES cells, SE structures primarily encompass transcription factors ( Fig. 2e and Extended Data Fig. 3a) . In macrophages, chemokine and cytokine activity were the most prominent categories. In T lymphocytes, genes relevant to cytokine biology were preferentially linked to SEs. Moreover, cytokine-related genes were not linked to SEs in non-immune related cells such as myotubes (Extended Data Fig. 3b ). Thus, SEs are preferentially associated with genes that have a central role in the biology of specific cell lineages rather than a given class of genes (that is, transcription factors). In the case of T cells, SEs form an interactive network that reflects the biology of lymphocytes, their products and their mode of sensing the inflammatory environment.
We next ranked T-cell SEs on the basis of their p300 occupancy (Fig. 3a) . Again, SEs with the highest p300 occupancy were typically associated with genes encoding cytokines and their receptors. However, the greatest p300 enrichment was associated with the Bach2 locus, regardless of lineage subset (Fig. 3a, b) . This is of interest as BACH2 is a broad regulator of immune activation that acts by stabilizing immunoregulatory capacity and attenuating effector differentiation 13 . Notably, genetic variations within this locus are associated with numerous immunemediated diseases including rheumatoid arthritis 16 , Crohn's disease 17 , multiple sclerosis 18 , asthma 19 and type 1 diabetes 20 . These observations prompted us to investigate the effect of Bach2 deletion on the expression of SE-associated genes in T cells. Transcriptional profiling revealed that Bach2 deficiency significantly affected the expression of genes with SE architecture compared to those with TEs or no enhancer mark in T cells (Fig. 3c, d ). These findings were confirmed when we used synthetic RNA standards 'spiked-in' to rigorously normalize transcriptome data in wild-type and Bach2-deficient cells 21 (Methods; Extended Data Fig. 3c, d ). This transcriptional difference remained statistically significant when we controlled for higher levels of gene expression for SEassociated genes (Extended Data Fig. 3e ). Furthermore, loss of BACH2 led to the largest difference between SEs and TEs in comparison with other transcription factors such as STATs, BATF and IRF4 (Extended Data Fig. 4a, b ). In particular, 348 genes, 26% of those with SE structure in CD4 1 T cells, were repressed by BACH2 ( Fig. 3e and Extended Data Fig. 4c-e) . In addition to protein-coding genes, a subset of SE-linked ncRNAs (56) were also repressed by BACH2 (Fig. 3f) . Transcriptional upregulation at some of these domains correlated with the upregulation of nearby genes in Bach2-deficient cells (Fig. 3g and Extended Data Fig. 4f, g ). This previously unrecognized circuitry reveals that a subset of genes and noncoding transcripts endowed with SE architecture in CD4 1 T cells are tightly and negatively controlled by the 'guardian' transcription factor BACH2, which itself has a rich cassette of regulatory elements (Extended Data Fig. 4h) .
It has been shown that single-nucleotide polymorphisms (SNPs) associated with diseases relevant to a particular cell type are more enriched in SEs compared with TEs 2, 5 . CD4
1 T cells are important contributors to a wide variety of autoimmune diseases including rheumatoid arthritis. Thus, we explored the extent to which rheumatoid-arthritis-associated genetic variants were situated within SEs. We delineated SEs in human CD4
1 T-cell subsets and found that 26% of the SNPs highly associated with rheumatoid arthritis 7 (27/101) fell within SEs (Fig. 4a ). In contrast, only 7% of rheumatoid arthritis SNPs overlapped with TEs (Fig. 4a) . Controlling for differences in the size of genomic regions, we found that the number of SNPs per 10 Mb of SEs was significantly higher than that in TEs (Fig. 4a) . Genetic variants associated with other autoimmune disorders such as inflammatory bowel disease, multiple sclerosis and type 1 diabetes also exhibited preferential enrichment in CD4 a, The histone acetyltransferase p300 is distributed asymmetrically across the genome in CD4
1 T cells with a subset of enhancers (SEs) that bind exceptionally high amounts of p300 (see Source Data). b, Closely related CD4 1 T-cell populations have distinctive SE landscapes. Venn diagram depicts shared and unique SE domains in T-cell subsets. c, SE-associated genes are highly transcribed compared with TE-associated genes. Proximity measures were used to assign SEs and TEs to their target genes (P values, Wilcoxon rank-sum test). RPKM, reads per kilobase of exon per million. d, Presence of lineage-specific SEs predicts cell-selective expression. Three groups of genes associated with unique SE structure in each lineage were defined as T H 1-, T H 2-and T H 17-specific SE genes. The expression of lineage-specific SE-associated genes was more significant in the corresponding lineage (P values, Wilcoxon rank-sum test). e, SE domains are themselves transcribed in CD4 1 T cells. The list of ncRNAs was derived from the map of intergenic transcripts in T-cell subsets 11 . One-third of ncRNAs in T cells (501/1,524) were transcribed from an SE. f-h, The SE structure differentiates highly lineage-specific and dynamic noncoding transcripts from constitutively expressed transcripts across T-cell lineages. f, g, Pearson correlation coefficients for transcription levels between each pair of differentiation stages were calculated for 501 ncRNAs with SEs (f) and 1,023 ncRNAs without SEs (g). h, ncRNA transcripts with SEs have a greater standard deviation across differentiation stages compared to those without SEs.
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We refined these observations by examining genes that were affected by rheumatoid-arthritis-associated genetic variants, focusing on 98 candidate genes associated with rheumatoid arthritis 7 . While SEs in muscle cells showed little association (Fig. 4b) , rheumatoid arthritis risk genes were preferentially associated with SEs in cytotoxic natural killer cells (CD56 ). However, the strongest enrichment occurred in CD4 1 T cells, where half of the rheumatoid arthritis risk genes (53/98) were linked to CD4 1 T-cell SEs (Fig. 4b) . SE structures are thought to be particularly sensitive to perturbation owing to the cooperative and synergistic binding of numerous factors at these domains 3 . Given the enrichment of STATs at SEs and the prevalence of SEs at cytokines and their receptors, we measured the effect of tofacitinib, a JAK inhibitor recently approved by the US Food and Drug Administration for the treatment of rheumatoid arthritis, on T-cell transcriptomes. We found that tofacitinib treatment had a significantly greater impact on the transcription of genes with SEs than TEs (Extended Data Fig. 5b) . Moreover, when genes were ranked on the basis of their transcript levels in T cells, the most highly expressed genes with SEs showed a larger change in their expression compared to those without SEs, emphasizing that tofacitinib discriminates genes with SE structure (Extended Data Fig. 5c ). Although harbouring the strongest SE in T cells, BACH2 levels were not affected by acute tofacitinib treatment, suggesting that BACH2 is regulated in a JAK/STAT-independent manner. Finally, we related the effect of this rheumatoid arthritis drug to the genetics of the disease and found that tofacitinib treatment disproportionately affected the expression of rheumatoid arthritis risk genes with SE structures in CD4
1 T cells compared with those lacking this chromatin feature ( Fig. 4c and Extended Data Fig. 5d ). Furthermore, tofacitinib treatment selectively affected inflammatory bowel disease 22 and multiple sclerosis 23 risk genes with SEs (Extended Data Fig. 6 ). We have defined the T H -cell SE landscape in the hope of better defining key regulatory nodes in a non-biased fashion. We found that in T cells these nodes largely comprise cytokine and cytokine receptor genes. Thus, T-cell 'identity' relates largely to the precise regulation of these key effectors and sensors. However, a predominant SE-associated gene in all T-cell lineages was Bach2, which may represent the first example RNA abundance (log 2 TPM) 
Enhancers ranked by p300 increasing load
Figure 3 | Bach2 is endowed with the highest p300-enriched SE in T cells.
a, Ranked order of p300-loaded enhancers in T-cell subsets identifies Bach2 as the strongest SE-associated gene in CD4 1 T cells. b, The Bach2 locus, the top ranked SE, exhibits an exceptional amount of p300 binding. c, d, BACH2 preferentially represses SE genes. Wild-type (WT) and Bach2-deficient CD4 1 T cells were polarized to induced regulatory T cells (iT reg cells) and were processed for total RNA extraction (n 5 3). Normalized transcript abundance measured by RNA-seq (RPKM) was evaluated in wild-type and Bach2-deficient cells at SE-and TE-associated genes and compared to the remaining genes. Cumulative distribution (c) and violin plots (d) show the (log 2 ) fold change in gene expression for wild-type versus Bach2-deficient cells (see Source Data).
e, Gene set enrichment analysis (GSEA) of SE-associated genes reveals that SE genes are enriched in genes repressed by BACH2. ES, enrichment score; NES, normalized enrichment score. f, BACH2 affects a subset of noncoding transcripts at SE domains. Overall, 56 ncRNAs with SE structures are repressed while 32 transcripts are induced by BACH2 (see Source Data). P values, Wilcoxon rank-sum test. g, BACH2-associated repression of a noncoding transcript with an SE architecture correlates with the transcriptional repression of a nearby gene (Ifngr1). Direct BACH2 binding along with the transcript levels in wild-type and Bach2-deficient cells measured by RNA-seq were depicted in a 140 kb window accommodating the Ifngr1 gene. TPM, tags per million. 1 T cells at rheumatoid arthritis risk genes with or without SEs (three donors). To ensure accurate inference of the effect of tofacitinib on the transcriptome, spiked-in RNA standards were added and gene expression levels (RPKM) were renormalized based on the spiked-in standards (P values, Wilcoxon rank-sum test).
G2015 Macmillan Publishers Limited. All rights reserved of a class of transcriptional regulators that broadly constrains transcription at SEs. Furthermore, SNPs associated with immune-related diseases were enriched at T-cell SEs, and a drug, which blocks cytokine signalling and is clinically efficacious in autoimmune disease, preferentially impacted SE-associated genes. Hence, our study provides a systematic approach by which the SE map of relevant cell types can be integrated with human genetics to discover drug target genes.
Online Content Methods, along with any additional Extended Data display items and Source Data, are available in the online version of the paper; references unique to these sections appear only in the online paper. A. Richard and E. Mathe for critically reading this manuscript. We are grateful to R. Fig. 1 summarizes ChIP-seq data sets generated or used for this data set along with relevant antibodies. Cell culture and stimulation for tofacitinib-treated human T cells. Whole blood from healthy donors was provided from the NIH blood bank and informed consent was obtained from subjects. To obtain lymphocyte population, heparinized whole blood from healthy donors was separated by Ficoll Paque PLUS (Sigma). Naive CD4 1 CD45RA 1 CD45RO 2 T-cell population was sorted on a FACS Aria III (BD Bioscience). Cells were activated by plate-bound anti-CD3/anti-CD28 (10 mg ml 21 ) in supplemented RPMI 1640 medium containing 10% FCS, 2 mM glutamine, 100 IU ml 21 penicillin, 0.1 mg ml 21 streptomycin, 20 mM HEPES buffer (all from Invitrogen) for 3 days and cultured in the presence of IL-2 for 1 day. During T-cell activation, cells were treated with the indicated concentrations of CP-690,550 (tofacitinib). RNA-seq preparation. Total RNA was prepared from approximately 1 million cells by using mirVana miRNA Isolation Kit (AM1560, ABI). Two-hundred nanograms to 1 mg of total RNA was subsequently used to prepare RNA-seq libraries by using TruSeq SR RNA sample prep kit (FC-122-1001, Illumina) or by a combination of NEBNext RNA library prep kit (New England BioLabs) and Ovation SP Ultralow DR Multiplex system (Nugen) by following the manufacturer's protocol. The libraries were sequenced for 50 cycles (single read) with HiSeq 2000 (Illumina). Where indicated, ERCC RNA spike-in mix 1 (Invitrogen) was added to the samples based on the cell counts (1 ml of 1/10 dilution to 1 million cells). RNA-seq analysis. RNA-seq libraries made by Illumina TruSeq were first trimmed using 'cutadapt' with TruSeq Indexed Adapters. An error rate of 0.1 was chosen for 'cutadapt'. Overall, the percentage of trimmed reads was lower than 3% of the total reads across different libraries. Trimmed fastq files were then aligned to mm9 or hg19 reference genomes using tophat with bowtie2 indexes derived based on UCSC annotations. The normalization of RNA-seq libraries shown on the genome browser was carried out using 'bedtools genomecov' to 'scale' the bam files to tags-per-million values. 'HT-seq' was used to find the read counts across the UCSC reference genome and DEseq was further employed to characterize differentially regulated genes where repeats were available (Bach2-deficient RNA-seq). RNA-seq analysis of Bach2-deficient cells. Wild-type and Bach2-deficient naive (CD44 2 CD62L 1 CD25
2 ) CD4 1 cells were isolated to .95% purity from C57BL/6 mice reconstituted with mixtures of wild-type and knockout OT-II TCR-transgenic bone marrow. Cells were stimulated at 1 3 10 5 cells per 96-well plate coated in 5 mg ml 21 anti-CD3 in the presence of soluble anti-CD28 (5 mg ml
21
), 100 IU recombinant human IL-2 and 5 ng ml 21 recombinant human TGF-b for 3 days. Cells were counted using a haematocytometer, or analysed by FACS for cell size or intracellular Foxp3 content. Cells were harvested and subjected to total RNA extraction (Qiagen RNeasy Plus kit with column-based DNA removal). RNA-seq with spiked-in standards. ERCC RNA spike-in mix 1 (Invitrogen) was added to samples based on the cell counts (1 ml of 1/10 dilution to 1 million cells). The ERCC RNA Spike-In Control Mixes used here comprise a set of 92 polyadenylated transcripts that mimic natural eukaryotic mRNAs. On the basis of page 12 of the ERCC manual, we calculated the concentrations of the RNA molecules added to total RNA (that is, number of copies of spiked-in molecules per million cell) (Source Data associated with Fig. 3 ). It is clear that the standards cover a wide range of copy numbers. Spiked-in RNA-seq analysis. The spiked-in RNA-seq libraries were subsequently sequenced on Illumina HiSeq 2000 and then trimmed using 'cutadapt' with TruSeq Indexed Adapters. The sequences of the ERCC synthetic spiked-in RNAs (http:// tools.invitrogen.com/downloads/ERCC92.fa) were then added to both mouse and human genomes (genome.fa). The exon reference (http://tools.invitrogen.com/ downloads/ERCC92.gtf) has also been added to the UCSC exon reference.
New bowtie indexes were then built and reads were aligned to the newly built genomes using tophat. The RPKM (reads per kilobase of exon per million) was then computed for each gene and synthetic spiked-in RNA using cufflinks. To renormalize the RNA-seq data using spiked-in control, we followed the same procedure as previously recommended 21 . We used a loess regression to renormalize the RPKM values by using only the spiked-in values to fit the loess. The affy package in R provides a function, loess.normalize, which will perform loess regression on a matrix of values (defined by using the parameter mat) and allows for the user to specify which subset of data to use when fitting the loess (defined by using the parameter subset). For this application the parameters mat and subset were set as a matrix of all RPKM values and the row indices of the ERCC spiked-ins, respectively. The default settings for all other parameters were used. The result of this was a matrix of RPKM values normalized to the control ERCC spiked-ins. Source Data associated with Fig. 3 quantitates the fraction of spiked-in tag counts in each RNA-seq library when tag counts were generated using ''htseq-count-mode5intersection-nonemptystranded5no''. ChIP-seq. For p300, we chemically crosslinked and sonicated cells to generate fractionated genomic DNA. ChIP was performed by using anti-p300 (sc-585, Santa Cruz Biotechnology). The DNA fragments were blunt-end ligated to the Illumina adaptors, amplified, and sequenced by using the Illumina Genome Analyzer II (Illumina). Sequence reads of 25 or 36 bp were obtained by using the Illumina Analysis Pipeline. Publically available ChIP-seq data sets are listed in Source Data associated with Fig. 1 and were obtained from several published studies [12] [13] [14] [15] [25] [26] [27] [28] . ChIP-seq analysis. ChIP libraries were sequenced for 36 or 50 cycles on an Illumina Genome Analyzer II or HiSeq 2000, respectively, according to the manufacturer's instructions. ChIP libraries were aligned to mm9 or hg19 reference genomes using bowtie2 with bowtie indexes derived based on UCSC annotations and Phred133 selected for qualities. Source Data associated with Fig. 1 summarizes ChIP-seq data sets generated or used for this study along with relevant antibodies. Peak calling for all transcription factors and p300 binding was performed by macs14 (ref. 29) using P value 5 1 3 10
27
. The control library for all peak-calling libraries was the input DNA performed under T H 0 condition. Peaks with false discovery rate (FDR) values more than 30% were further excluded. Peak intensities ('tags' column) were normalized as tags-per-million reads in the original library. Peak calling for H3K27ac libraries was performed using SICER 30 where the window size 5 200 bp, gap size 5 200 bp and E value 5 200. To visualize and normalize ChIP-seq libraries on the UCSC genome browser, we used 'bedtools genomecov' to 'scale' the bam files to tags-per-million values. Furthermore, 'wigToBigWig' was used to generate bigwig files. y-Axis in all gene tracks is in tags per million (TPM). Delineation of SEs and typical enhancers TEs. To accurately delineate SE domains, we followed the same approach that was proposed earlier [2] [3] [4] . We first merged genomic regions within 12.5 kb of one another (using mergeBed in bedtools). We then ranked all regions in a cell type by increasing total ChIP-seq occupancy of p300 or H3K27 acetylation, scaled the data such that the x and y axes were from 0-1 by normalizing to the largest value, and plotted the intensity of ChIP-seq (Fig. 1a) . These plots revealed a clear point in the distribution of enhancers where the occupancy signal began increasing rapidly. To geometrically define this point, we found the x-axis point for which a line with a slope of 1 was tangent to the curve. As suggested by Young and colleagues, we defined genomic regions above this point to be SEs. All genomic regions below that point that did not harbour promoters (65 kb of RefSeq transcription start sites) were then referred as TEs. The single map of SEs in CD4 1 T cells was constructed by merging maps of T H 1, T H 2 and T H 17 SEs (unionBedGraphs). Similarly, TEs in each lineage were delineated as described and then merged in different lineages to build one map for TEs. Since SEs in one lineage can be TEs in other lineages, SE coordinates were then excluded from the final TE map for CD4 1 T cells. Source Data associated with Figs 1 and 4 summarize the coordinates of SEs in both human and mouse in our study. Delineation of cell-type specific SEs. To define cell-type-specific and shared SE domains, we started from the merged map of SEs in T H 1, T H 2 and T H 17 cells (Source Data associated with Fig. 1 ). We then used 'bedtools intersect' with -f 0.1, 0.3, 0.5 or 0.7 with -a being the coordinate of merged map and -b being the SE coordinates in the corresponding condition and reporting -c in the output (for each entry in A, report the number of overlaps with B and reporting 0 for A entries that have no overlap with B) (Fig. 1b and Extended Data Fig. 1b) . We used the pheatmap function to demonstrate the shared and unique SEs based on the outputs of 'bedtools intersect' for the three cell types. Figure 1b corresponds to f 5 0.1. Characterizing SE-and TE-associated genes. SE-and TE-associated genes were defined based on the closest genes to these genomic regions (bedtools closest) using RefSeq coordinates of genes. As described in this package, closestBed first searches for features in B (gene coordinates) that overlap a feature in A (SE coordinates). If overlaps are found, gene coordinates that overlap the highest fraction of SE regions are reported. Then in the case of multiple genes overlapping SEs, the gene with the highest fraction of overlap is reported. If no overlaps are found, closestBed looks for the feature in B that is closest (that is, least genomic distance to the start or end of A) to A. Transcription at T H -specific SE genes. We delineated SE genes as described earlier for T H 1, T H 2 and T H 17 p300 binding (Fig. 1d) . We defined a gene to be specific to a lineage if that gene was not present in SE-associated genes in the other two lineages. We then showed the log 2 RPKM values for this list of genes across three different lineages. P values were calculated using the Wilcoxon rank-sum test. Characterization of long ncRNAs associated with SEs. The list of transcribed ncRNAs in T cells was compiled from Hu et al.
11
. Hu et al. 11 performed the following steps for the identification of ncRNA clusters: (1) call RNA-seq read enriched islands from intergenic regions using SICER (window 5 100 bp, gap 5 200 bp, E value 5 100); (2) keep islands shared by duplicates; (3) pool islands from all LETTER RESEARCH samples, independently done for data sets from total RNA-seq and from PolyA 1 RNA-seq; (4) cluster neighbouring islands based on similarity in expression profiles across different samples (r . 0.8). Transcribed regions that overlapped SEs were identified using the countOverlaps function in the GenomicRanges package in R (Fig. 1e) . To quantitate the correlation levels in transcripts across different T-cell lineages and time points, we used the 'cor' function in R with 'pearson' as 'method' (no log 2 transformation was performed prior to the calculation of correlation) (Fig. 1f, g ). Transcript levels for polyA RNAs used for this analysis were extracted from the supplementary table provided in ref. 11 . Genomic coordinates of these two groups of ncRNAs are provided in Source Data associated with Fig. 1 . Cumulative distribution of ncRNAs with and without SEs. We used the 'rowSds' function from the library 'matrixStats' in R to calculate the standard deviation in each row for expression levels of ncRNAs with and without SEs. We used ggplot and stat_ecdf() to plot the cumulative distribution of standard deviation in these two groups of ncRNAs. Cumulative distribution in Fig. 1h shows quantitative shift in standard deviation of transcript levels for ncRNAs with SEs relative to those without SEs (P value 5 1.326 3 10
27
, Kolmogorov-Smirnov test). Profile of transcription factor binding at SE genomic regions. To plot the normalized tags-per-million transcription factor binding at SEs and their flanking 40 kb regions, we used the 'ngs.plot.r' package 31 (for example, Fig. 2a) . To generate the enrichment of transcription factors at T H -preferred SEs, we started by counting all tags in .bed files for each transcription factor binding using ''bedtools coverage -counts'' across the one map of SEs in T cells (T H 1/T H 2/T H 17 merged). Furthermore, in Fig. 2d we selected the T H (1, 2, 17)-preferred SEs as genomic regions identified based on overlapping fraction 5 0.1 identified in Fig. 1b . Extended Data Fig. 2a was generated by using ngs.plot on the same set of cell-type-specific coordinates. The normalization has been done as described previously 31 : the coverage data were normalized in two steps. In the first step, the coverage vectors were normalized to have equal length using spline fit. In this case, a cubic spline is fit through all data points and values are taken at equal intervals. This first step of length normalization leads to regions of variable sizes to have equal lengths and is particularly useful for custom regions. The purpose of the second step is to normalize vectors against the corresponding library size-that is, the total read count. Profile of transcription-factor binding at constituent elements of SEs. We first recovered the original peak regions for p300 binding (constituent enhancers) within SEs from outputs of the peak-calling method (MACS) overlapping SEs/TEs. We then used the HOMER 'annotatePeaks.pl' function to plot the enrichment of transcription factor binding at constituent enhancers in SEs and TEs (Extended Data  Fig. 2c) . GO analysis for SE-associated genes. In Fig. 2e , GO enrichment for SE genomic coordinates was carried out using GREAT 24 with default parameters. The top ten terms based on binomial P values were selected in Fig. 2e . In a completely different approach, we characterized the closest genes to SEs. The top GO molecular functions in terms of GSEA ''Investigate Gene Sets'' were then selected. To calculate the statistical significance of these enrichments, we randomly moved the SE regions around the genome 10 5 times, delineated the closest gene sets to the random genomic domains, and assessed the relative proportion of a gene set that is captured in the actual data versus the shifted SEs. P values for this permutation test are reported in Extended Data Fig. 3a .
GO functional category relevant to cytokine binding is enriched at SE-associated genes in T cells and to a lesser extent in macrophages but not in mouse ES cells and myotubes (Extended Data Fig. 3b) . To explore whether 'cytokine binding' is specific to the SE structure in CD4
1 T cells, we explored its association within the SE structures of other cell types. The GO molecular function associated with cytokine binding (GO:0019955) was chosen. SE-associated genes in myotubes were used from Whyte et al. 4 . SE regions in mouse ES cells and macrophages were chosen based on data sets reported in Source Data associated with Fig. 1 . To calculate the statistical significance of this gene category, we shuffled the SE regions of mouse ES cells, macrophages, myotubes and CD4 1 T cells around the genome 10 5 times, delineating the gene sets in proximity to the random genomic domains associated with each cell type. We then assessed the relative proportion of the gene set captured in the actual data versus the shifted SEs. P values for this permutation test are reported in the bar graph in Extended Data Fig. 3b . Analysis of RNA-seq data from Bach2-deficient cells. The log 2 fold change of average RPKM values in wild-type and knockout repeats were calculated for SE genes and an equal number of randomly selected TE and other genes in the violin plots ( Fig. 3d and Extended Data Fig. 3d ). In Extended Data Fig. 3c, d , the RPKM values for the spiked-in measurements were renormalized based on the spiked-in standards. We used ggplot and geom_violin(scale 5 ''area'') to plot the impact of loss of BACH2 on gene expression. All genes in SEs, TEs, or the rest of genes were used for the cumulative distribution plots (Fig. 3c and Extended Data Fig. 3c ). In Extended Data Fig. 3e , we focused on the top 500 highly expressed genes and explored the effect of BACH2 on three categories among them: genes with SEs (77), with TEs (125), and without either SEs or TEs (298). Expression levels among these three categories of genes were comparable (Wilcoxon rank-sum test P value 5 0.644). However, BACH2 selectively affected highly expressed SE genes in contrast to those with TEs or no enhancers (Kolmogorov-Smirnov test P value 5 9.813 3 10 27 and 4.669 3 10
28
). GSEA plot. The 'gene-set' for GSEA was generated based on genes closest to SEs with minimum 1 RPKM value in any of the three lineages (T H 1, T H 2, T H 17 cells). Three repeats for wild-type and Bach2-knockout RNA-seq data were used in the GSEA analysis with default settings (Fig. 3e) . The P value for the enrichment was calculated as 0 although -nperm 5 10000 was used (with command-line usage of GSEA). In the case of spiked-in GSEA analysis (Extended Data Fig. 4c) , two repeats for wild-type and knockouts of renormalized spiked-in data were used. Pie chart demonstrating Bach2-dependent SE genes. BACH2 up-or downregulated genes (Source Data associated with Fig. 3) were delineated by the 'DEseq' package in R with FDR , 0.05 and fold change . 1.5. Tag counts were calculated using ''htseq-count-mode5intersection-nonempty-stranded5no'' (Extended Data  Fig. 4d ). Three repeats of RNA-seq data for wild-type and knockout samples (no spiked-in) were used (Source Data associated with Fig. 1 ). Direct targets of BACH2 were identified based on BACH2 ChIP-seq data at these two groups of genes. A list of SE genes with at least 1 RPKM expression in T H 1, T H 2 or T H 17 cells was used for this analysis. Characterization of BACH2-dependent noncoding RNAs. We used ''bedtools coverage -counts'' to quantitate the enrichment of RNA-seq reads at 501 ncRNAs with SE structure in wild-type and Bach2-knockout cells (Source Data associated with Fig. 3 ). Transcript levels were further normalized to the size of each library (tags per million) and the average of enrichment in three repeats were calculated. Next, we selected ncRNAs with SE structure that were up-or downregulated by BACH2 (.4 fold-change) (Fig. 3f) . Impact of transcription factors on SE-and TE-associated genes. The fold change in RPKM values between wild-type and knockout samples was calculated for SE genes and an equal number of randomly selected TE genes (Extended Data Fig. 4a ). For each transcription factor, the difference between SEs and TEs was quantitated using Kullback-Leibler distance between the two distributions for fold changes in the two groups of genes using the KL.dist function in the FNN library in R (Extended Data Fig. 4b ). The largest difference between SEs and TEs generated because of loss of BACH2, STAT4 and STAT6 suggests the more selective impact of these transcription factors on SEs. Pruning SNPs. To ensure that the SNPs associated with disease are in physically independent segments of the genome, we pruned our lists of SNPs (Fig. 4a) . Data from the 1000 Genomes (release 20110521) were downloaded from the 1000 Genomes open ftp site. SNPs that were present in each of the six disease conditions were extracted. For each disease, the all-versus-all pairwise r 2 values were calculated. Finally, all variants were greedily pruned until no pair had an r 2 value greater than the threshold (0.5). The number of SNPs pruned for each disease and their genomic coordinates can be found in Source Data associated with Fig. 4 . T-cell SEs in human and enrichment of SNPs. Human SEs in T-cell subsets were characterized based on H3K27ac data in T H 1, T H 2 and T H 17 cells (Source Data associated with Fig. 4) . The methodology for the delineation of SEs for human T cells was the same as the one described for the mouse data. We referred to the merged map of the T H 1, T H 2 and T H 17 SEs as the single map of SEs in CD4 1 T cells (Source Data associated with Fig. 4) . The lists of tag SNPs for all traits except RA were extracted from the GWAS catalogue (December 2013) and only those with P values less than 1 3 10 28 were selected. The list of 101 RA SNPs were chosen from the recent meta-analysis of RA GWASs 7 . The percentages of SNPs within SEs/TEs were calculated based on the number of SNPs falling into the genomic domains labelled as SEs/TEs. To account for the size of the genome that these two types of enhancers span, we divided the number of SNPs enriched in SEs/TEs by the total size of SEs (66.5338 Mb) and TEs (63.12915 Mb) and reported the number of SNPs in every 10 Mb of the genome in Fig. 4a . The permutation test for the enrichment P value was calculated by generating 10 6 permutations of SEs and TEs in the genome (excluding unmappable regions in each permutation) and considering the number of iterations where the number of overlapping SNPs with random SEs/TEs exceeded the observed ones in CD4 1 T cells. SNPs in linkage disequilibrium with the list of tag SNPs were determined from the 1000 Genomes Project using r 2 5 0.9 and distance limit 5 500 using SNAP toolbox (Extended Data Fig. 5a ). RA risk genes and SEs. The list of 98 rheumatoid arthritis (RA) risk genes was extracted from the study of Plenge and colleagues 7 (Fig. 4b) . H3K27ac data for muscle, CD14
1 and CD56 1 cells are summarized in Source Data associated with Fig. 4 . Quantitating the effect of tofacitinib on different groups of genes. For each donor (except donor 4), the RPKM values with spiked-in were renormalized and the fold changes at SE/TE genes were reported (Fig. 4c) . No spiked-in was used for
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the RNA-seq analysis of donor 4. The P values were calculated based on Wilcoxon signed-rank test (wilcox.test function in R) for violin and box plots. The violin plots used 'scale 5 'area''. In Extended Data Fig. 4c , for each donor, the top 100 highly expressed genes in non-treated RNA-seq data were selected and categorized as having SEs or not. IBD, MS and T2D risk genes and SEs. The candidate genes associated with RA 7 , inflammatory bowel disease (IBD) 22 , multiple sclerosis (MS) 23 and type 2 diabetes (T2D) 32 were chosen based on a recent meta-analysis of GWAS data. More than half of RA risk genes (53/98) accommodated SEs in CD4 1 T cells. In line with the enrichment of SNPs associated with IBD and MS in T-cell SEs (Fig. 4a) , around half of IBD (91/216) and MS risk genes (36/87) were associated with SEs in T cells. In contrast, T2D risk genes showed little association with SEs (4/65) (Fisher's exact test, P value 5 0.4). RA and IBD risk genes with SEs are selectively targeted by a JAK inhibitor, tofacitinib. Cumulative plots depict the fold change in expression (log 2 ) after 0.3 mM tofacitinib treatment of human CD4
1 T cells at RA (Extended Data Fig. 6b ), IBD (Extended Data Fig. 6c ) and MS (Extended Data Fig. 6d) In macrophages, chemokine and cytokine activity were the most prominent categories. Using a complementary approach to that described in Fig. 2a , we characterized genes in proximity to SEs. The top GO molecular functions using GSEA were chosen. To calculate the statistical significance of these gene categories, we shuffled the SE regions around the genome 10 5 times, delineating the gene sets in proximity to the random genomic domains. We then assessed the relative proportion of a gene set captured in the actual data versus the shifted SEs. 2Log 10 P values for this permutation test are reported in the bar graph. b, GO functional category relevant to cytokines binding is enriched at SE-associated genes in T cells and, to a lesser extent, in macrophages but not in mouse ES cells (mESCs) or myotubes. To explore whether ''cytokine binding'' is specific to the SE structure in CD4
1 T cells, we explored its association within the SE structures of other cell types. The GO molecular function associated with cytokine binding (GO:0019955) was chosen. To calculate the statistical significance of this gene category, we shuffled the SE regions of mouse ES cells, macrophage, myotubes and CD4 1 T cells around the genome 10 5 times, delineating the gene sets in proximity to the random genomic domains associated with each cell type. We then assessed the relative proportion of the gene set captured in the actual data versus the shifted SEs. P values for this permutation test are reported in the bar graph. c, d, BACH2 preferentially represses SE genes. Wild-type and Bach2-deficient CD4 1 T cells were polarized to induced regulatory T cells (iT reg cells) and were subjected to total RNA extraction. RNA standards 'spiked-in' were added in proportion to the number of cells present in the sample. The resulting transcriptome data measured by RNA-seq were processed by using standard normalization methods and then renormalized based on spiked-in reads (RPKM) (see Methods). Transcript abundance measured by RNA-seq was evaluated in wild-type and Bach2-deficient cells at SE-and TE-associated genes compared to remaining genes (RPKM). Cumulative distribution (c) and violin plots (d) show the (log 2 ) fold change in gene expression for wild-type versus Bach2-deficient cells for these three groups of genes. SE genes are preferentially affected by loss of BACH2 compared with TE genes (P value , 2.2 3 10
216
, Kolmogorov-Smirnov test) or remaining genes (P value , 2.2 3 10
, Kolmogorov-Smirnov test). P values for the violin plots (d) were calculated using the Wilcoxon rank-sum test. e, BACH2 selectively affects SE genes and such selectivity remains statistically significant when controlling for the higher levels of gene expression for the SE genes. Genes were ranked based on their transcriptional activity in T reg cells. We focused on the top 500 highly expressed genes and explored the effect of BACH2 on three categories among them: genes with SEs (77), with TEs (125), and without either SEs or TEs (298). Expression levels among these three categories of genes were comparable (Wilcoxon rank-sum test, P value 5 0.644). However, BACH2 selectively affected highly expressed SE genes in contrast to those with TEs or no enhancers (Kolmogorov-Smirnov test, P value 5 9.813 3 10 27 and 4.669 3 10
28
).
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Extended Data Figure 4 | BACH2 acts as a guardian transcription factor. a, b, Loss of BACH2, STAT4 and STAT6 has the most selective impact on the expression of SE genes. a, The fold change in expression (in RPKM) between wild-type and knockout samples was calculated for SE genes and an equal number of randomly selected TE genes. b, For each transcription factor, the difference between SEs and TEs was quantitated using Kullback-Leibler distance. The larger difference between SEs and TEs for BACH2, STAT4 and STAT6 suggests the more selective impact of these transcription factors on SEs. STAT4 and T-BET transcriptome data were under T H 1, STAT6 under T H 2, STAT3, BATF and IRF4 under T H 17 and BACH2 under iT reg conditions. c, SE-associated genes in CD4
1 T cells are repressed by BACH2. To ensure accurate inference of the effect of BACH2 on the transcriptome, spiked-in RNA standards were added. The gene set enrichment analysis (GSEA) of SEassociated genes revealed that SE genes were enriched in genes repressed by BACH2 when transcript levels were renormalized using spiked-in RNA standards. d, BACH2 acts as a repressor of SE-associated genes. Comparison of the transcriptome data measured by RNA-seq in wild-type and Bach2-deficient cells (DE-seq analysis for three wild-type and knockout samples, FDR , 0.05 and fold change . 1.5) revealed that 348 SE genes were repressed while 176 were induced by this protein. Integration of BACH2 binding data measured by ChIP-seq characterized the direct targets of BACH2. e, The GSEA of TE-associated genes revealed that TE genes are not enriched in genes repressed by BACH2. f, g, BACH2-associated transcriptional repression at some SE domains correlates with the downregulation of nearby genes such as Rbpj (f) and Socs1 (g). h, Genes and noncoding transcripts endowed with SE architecture in CD4
1 T cells are tightly and negatively controlled by the 'guardian' transcription factor BACH2, which itself has a rich cassette of regulatory elements. Examples were selected based on direct binding of BACH2 at the gene body or SE regions measured by ChIP-seq.
Extended Data Figure 5 | RA risk genes with SE structure are selectively targeted by a JAK inhibitor, tofacitinib. a, Genetic variants in high linkage disequilibrium (LD) with SNPs associated with autoimmune disorders such as RA, IBD, MS and T1D exhibit preferential enrichment in SEs versus TEs in human CD4 T cells. Variants in LD with SNPs in each disease were determined from the 1000 Genomes Project using r 2 5 0.9 and distance limit 5 500 by SNAP toolbox. The heatmap depicts the percentages of SNPs and total number of SNPs per 10 Mb within SEs and TEs. b, Tofacitinib treatment has a selective impact on SE versus TE genes in human T cells. Violin plots depict the fold change (log 2 ) in transcript levels due to tofacitinib treatment at SE versus TE genes in CD4 1 T cells. The P values were calculated based on the Wilcoxon signed-rank test. c, Highly expressed genes in T cells with SEs are selectively affected by tofacitinib. For each donor, the top 100 highly expressed genes in non-treated cells were selected and categorized as having SEs or not. The P values were calculated based on the Wilcoxon signed-rank test. d, RA risk genes with SEs are selectively targeted by a JAK inhibitor, tofacitinib. Violin plots depict the fold change in expression (log 2 ) after tofacitinib treatment of human CD4
1 T cells at RA risk genes with or without SEs (a donor with no spiked-in standard in RNA-seq). P values were calculated using the F-test.
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